Kornitzer Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Hold |
12,312
| – | – | 0.03% | 357 |
|
|
2025
Q1 | $1.24M | Buy |
12,312
+1,725
| +16% | +$174K | 0.03% | 350 |
|
|
2024
Q4 | $946K | Hold |
10,587
| – | – | 0.02% | 389 |
|
|
2024
Q3 | $887K | Sell |
10,587
-146,104
| -93% | -$12.2M | 0.02% | 398 |
|
|
2024
Q2 | $12.1M | Buy |
156,691
+125
| +0.1% | +$9.63K | 0.23% | 122 |
|
|
2024
Q1 | $10.7M | Buy |
156,566
+2,025
| +1% | +$139K | 0.2% | 160 |
|
|
2023
Q4 | $8.93M | Sell |
154,541
-171,475
| -53% | -$9.91M | 0.17% | 192 |
|
|
2023
Q3 | $17.2M | Buy |
326,016
+3,975
| +1% | +$210K | 0.36% | 68 |
|
|
2023
Q2 | $17.4M | Sell |
322,041
-7,423
| -2% | -$402K | 0.34% | 77 |
|
|
2023
Q1 | $16.5M | Sell |
329,464
-26,350
| -7% | -$1.32M | 0.33% | 87 |
|
|
2022
Q4 | $16.5M | Sell |
355,814
-45,000
| -11% | -$2.08M | 0.33% | 81 |
|
|
2022
Q3 | $15.5M | Sell |
400,814
-16,866
| -4% | -$653K | 0.33% | 81 |
|
|
2022
Q2 | $15.6M | Sell |
417,680
-125,170
| -23% | -$4.67M | 0.31% | 90 |
|
|
2022
Q1 | $24M | Sell |
542,850
-39,050
| -7% | -$1.73M | 0.4% | 72 |
|
|
2021
Q4 | $24.7M | Sell |
581,900
-225
| -0% | -$9.56K | 0.37% | 85 |
|
|
2021
Q3 | $25.3M | Sell |
582,125
-275
| -0% | -$11.9K | 0.39% | 77 |
|
|
2021
Q2 | $24.9M | Sell |
582,400
-250
| -0% | -$10.7K | 0.37% | 86 |
|
|
2021
Q1 | $22.5M | Buy |
582,650
+89,900
| +18% | +$3.47M | 0.36% | 93 |
|
|
2020
Q4 | $17.7M | Buy |
492,750
+169,290
| +52% | +$6.09M | 0.3% | 120 |
|
|
2020
Q3 | $12.4M | Sell |
323,460
-128,891
| -28% | -$4.92M | 0.24% | 148 |
|
|
2020
Q2 | $15.9M | Buy |
+452,351
| New | +$15.9M | 0.32% | 112 |
|